• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基酸变异性对同种异体反应性的影响定义了一种功能距离,该距离可预测造血干细胞移植中允许的HLA - DPB1错配情况。

The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation.

作者信息

Crivello Pietro, Zito Laura, Sizzano Federico, Zino Elisabetta, Maiers Martin, Mulder Arend, Toffalori Cristina, Naldini Luigi, Ciceri Fabio, Vago Luca, Fleischhauer Katharina

机构信息

Institute for Experimental Cellular Therapy, Essen University Hospital, Essen, Germany; Unit of Molecular and Functional Immunogenetics, San Raffaele Scientific Institute, Milan, Italy.

Unit of Molecular and Functional Immunogenetics, San Raffaele Scientific Institute, Milan, Italy.

出版信息

Biol Blood Marrow Transplant. 2015 Feb;21(2):233-41. doi: 10.1016/j.bbmt.2014.10.017. Epub 2014 Oct 23.

DOI:10.1016/j.bbmt.2014.10.017
PMID:25445022
Abstract

A major challenge in unrelated hematopoietic stem cell transplantation (HSCT) is the prediction of permissive HLA mismatches, ie, those associated with lower clinical risks compared to their nonpermissive counterparts. For HLA-DPB1, a clinically prognostic model has been shown to be matching for T cell epitope (TCE) groups assigned by cross reactivity of T cells alloreactive to HLA-DPB1∗09:01; however, the molecular basis of this observation is not fully understood. Here, we have mutated amino acids (aa) in 10 positions of HLA-DPB1∗09:01 to other naturally occurring variants, expressed them by lentiviral vectors in B cell lines, and quantitatively measured allorecognition by 17 CD4(+) T cell effectors from 6 unrelated individuals. A significant impact on the median alloresponse was observed for peptide contact positions 9, 11, 35, 55, 69, 76, and 84, but not for positions 8, 56, and 57 pointing away from the groove. A score for the "functional distance" (FD) from HLA-DPB1∗09:01 was defined as the sum of the median impact of polymorphic aa in a given HLA-DPB1 allele on T cell alloreactivity. Established TCE group assignment of 23 alleles correlated with FD scores of ≤0.5, 0.6 to 1.9 and ≥2 for TCE groups 1, 2, and 3, respectively. Based on this, prediction of TCE group assignment will be possible for any given HLA-DPB1 allele, including currently 367 alleles encoding distinct proteins for which T cell cross reactivity patterns are unknown. Experimental confirmation of the in silico TCE group classification was successfully performed for 7 of 7 of these alleles. Our findings have practical implications for the applicability of TCE group matching in unrelated HSCT and provide new insights into the molecular mechanisms underlying this model. The innovative concept of FD opens new potential avenues for risk prediction in unrelated HSCT.

摘要

非亲缘造血干细胞移植(HSCT)中的一个主要挑战是预测允许的HLA错配,即与不允许的错配相比临床风险较低的错配。对于HLA-DPB1,一种临床预后模型已被证明与通过对HLA-DPB1∗09:01具有同种异体反应性的T细胞交叉反应性分配的T细胞表位(TCE)组相匹配;然而,这一观察结果的分子基础尚未完全了解。在此,我们将HLA-DPB1∗09:01的10个位置的氨基酸(aa)突变为其他天然存在的变体,通过慢病毒载体在B细胞系中表达它们,并定量测量来自6名非亲缘个体的17个CD4(+) T细胞效应器的同种异体识别。观察到肽接触位置9、11、35、55、69、76和84对中位同种异体反应有显著影响,但远离凹槽的位置8、56和57则没有。从HLA-DPB1∗09:01的“功能距离”(FD)得分定义为给定HLA-DPB1等位基因中多态性aa对T细胞同种异体反应性的中位影响之和。已建立的23个等位基因的TCE组分配分别与TCE组1、2和3的FD得分≤0.5、0.6至1.9和≥2相关。基于此,对于任何给定的HLA-DPB1等位基因,包括目前编码不同蛋白质且T细胞交叉反应模式未知的367个等位基因,都有可能预测TCE组分配。对其中7个等位基因中的7个进行了计算机模拟TCE组分类的实验验证。我们的发现对TCE组匹配在非亲缘HSCT中的适用性具有实际意义,并为该模型的分子机制提供了新的见解。FD的创新概念为非亲缘HSCT中的风险预测开辟了新的潜在途径。

相似文献

1
The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation.氨基酸变异性对同种异体反应性的影响定义了一种功能距离,该距离可预测造血干细胞移植中允许的HLA - DPB1错配情况。
Biol Blood Marrow Transplant. 2015 Feb;21(2):233-41. doi: 10.1016/j.bbmt.2014.10.017. Epub 2014 Oct 23.
2
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.无关供者造血细胞移植受者 HLA-DPB1 中 T 细胞表位匹配的效果:一项回顾性研究。
Lancet Oncol. 2012 Apr;13(4):366-74. doi: 10.1016/S1470-2045(12)70004-9. Epub 2012 Feb 15.
3
Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation.剖析 HLA-DPB1 表达的遗传控制及其与造血干细胞移植中结构不匹配模型的关系。
Front Immunol. 2018 Oct 5;9:2236. doi: 10.3389/fimmu.2018.02236. eCollection 2018.
4
Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.HLA-DPB1 T细胞表位匹配与非亲缘造血细胞移植结果之间的风险关联独立于HLA-DPA1。
Bone Marrow Transplant. 2014 Sep;49(9):1176-83. doi: 10.1038/bmt.2014.122. Epub 2014 Jun 23.
5
In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.通过功能距离预测无关造血干细胞移植中 HLA-DPB1 不合的非允许性
Blood Adv. 2018 Jul 24;2(14):1773-1783. doi: 10.1182/bloodadvances.2018019620.
6
Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation.非亲缘造血干细胞移植中相关的HLA-DPB1 T细胞表位差异的频率及靶向检测
Biol Blood Marrow Transplant. 2007 Sep;13(9):1031-40. doi: 10.1016/j.bbmt.2007.05.010. Epub 2007 Jul 20.
7
Immunopeptidome Analysis of HLA-DPB1 Allelic Variants Reveals New Functional Hierarchies.免疫肽组学分析 HLA-DPB1 等位基因变异揭示新的功能层次结构。
J Immunol. 2020 Jun 15;204(12):3273-3282. doi: 10.4049/jimmunol.2000192. Epub 2020 Apr 29.
8
From clones to immunopeptidomes: New developments in the characterization of permissive HLA-DP mismatches in hematopoietic cell transplantation.从克隆到免疫肽组学:造血细胞移植中允许性 HLA-DP 错配的特征新进展。
Best Pract Res Clin Haematol. 2024 Sep;37(3):101575. doi: 10.1016/j.beha.2024.101575. Epub 2024 Aug 28.
9
[Risk prediction and function evaluation by T-cell epitope model and expression model of HLA-DPB1 mismatching in unrelated-donor hematopoietic stem cell transplantations].[通过T细胞表位模型和人类白细胞抗原-DPB1错配表达模型对非血缘供者造血干细胞移植进行风险预测及功能评估]
Zhonghua Yi Xue Za Zhi. 2024 Mar 19;104(11):850-856. doi: 10.3760/cma.j.cn112137-20231203-01275.
10
HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse.在非亲缘造血干细胞移植项目中,HLA-DPB1配型会导致疾病复发率升高。
Hum Immunol. 2017 Nov;78(11-12):665-671. doi: 10.1016/j.humimm.2017.08.008. Epub 2017 Sep 5.

引用本文的文献

1
HLA and Non-HLA Factors for Donor Selection in Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide GvHD Prophylaxis.在采用移植后环磷酰胺预防移植物抗宿主病的造血干细胞移植中供体选择的人类白细胞抗原和非人类白细胞抗原因素
Cells. 2024 Dec 14;13(24):2067. doi: 10.3390/cells13242067.
2
Impact of inhibitory KIR ligand mismatch and other variables on outcomes following myeloablative posttransplant cyclophosphamide-based T-cell-replete haploidentical bone marrow transplantation.基于移植后环磷酰胺的清髓性、T细胞充足的单倍体相合骨髓移植后,抑制性杀伤细胞免疫球蛋白样受体(KIR)配体错配及其他变量对预后的影响
Front Immunol. 2024 Dec 16;15:1413927. doi: 10.3389/fimmu.2024.1413927. eCollection 2024.
3
Existence of HLA-Mismatched Unrelated Donors Closes the Gap in Donor Availability Regardless of Recipient Ancestry.
HLA 错配非亲缘供者的存在缩小了供者来源的差距,而与受者的种族无关。
Transplant Cell Ther. 2023 Nov;29(11):686.e1-686.e8. doi: 10.1016/j.jtct.2023.08.014. Epub 2023 Aug 14.
4
Assessment of HLA-DPB1 genetic variation using an HLA-DP tool and its implications in clinical transplantation.采用 HLA-DP 工具评估 HLA-DPB1 基因变异及其在临床移植中的意义。
Blood Adv. 2023 Sep 12;7(17):4809-4821. doi: 10.1182/bloodadvances.2022009554.
5
A combination of HLA-DP α and β chain polymorphisms paired with a SNP in the DPB1 3' UTR region, denoting expression levels, are associated with atopic dermatitis.HLA-DP α链和β链多态性与DPB1 3'非翻译区(UTR)区域中的一个单核苷酸多态性(SNP)相结合,该SNP表示表达水平,与特应性皮炎相关。
Front Genet. 2023 Jan 23;14:1004138. doi: 10.3389/fgene.2023.1004138. eCollection 2023.
6
Unrelated Stem Cell Donor HLA Match Likelihood in the US Registry Incorporating HLA-DPB1 Permissive Mismatching.美国注册系统中纳入 HLA-DPB1 允许性错配的无关供者 HLA 匹配可能性。
Transplant Cell Ther. 2023 Apr;29(4):244-252. doi: 10.1016/j.jtct.2022.12.027. Epub 2023 Jan 7.
7
HLA Factors versus Non-HLA Factors for Haploidentical Donor Selection.HLA 因素与非 HLA 因素在单倍体供者选择中的比较。
Transplant Cell Ther. 2023 Mar;29(3):189-198. doi: 10.1016/j.jtct.2022.11.027. Epub 2022 Dec 5.
8
Human T cells recognize HLA-DP-bound peptides in two orientations.人类 T 细胞以两种取向识别 HLA-DP 结合的肽。
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2214331119. doi: 10.1073/pnas.2214331119. Epub 2022 Nov 29.
9
The IPD-IMGT/HLA Database.免疫球蛋白和 T 细胞受体基因数据库(IMGT)/人类白细胞抗原数据库(HLA)。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1053-D1060. doi: 10.1093/nar/gkac1011.
10
A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation.一组结构相似的HLA-DPB1等位基因核心群体在造血细胞移植后驱动免疫许可。
Blood. 2022 Aug 11;140(6):659-663. doi: 10.1182/blood.2022015708.